Thiomersal in vaccines for human use - recent evidence supports safety of thiomersal-containing vaccines - Scientific guideline

This document updates provides CPMP recommendation on the use of thiomersal and other mercurial containing preservatives in vaccines.

A 2016 review of this guideline concluded that it remains up-to-date and relevant.

Keywords: Thiomersal, preservative, vaccines, immunoglobulins, antimicrobial, organomercuric

Current version

EMEA public statement on thiomersal in vaccines for human use - recent evidence supports safety of thiomersal-containing vaccines

Adopted Reference Number: EMEA/CPMP/VEG/1194/04/Adopted

First version

EMEA public statement on thiomersal containing medicinal products

Adopted Reference Number: EMEA/20962/99